HRP20211983T1 - Pripravci za i postupci stimuliranja matičnih stanica - Google Patents
Pripravci za i postupci stimuliranja matičnih stanica Download PDFInfo
- Publication number
- HRP20211983T1 HRP20211983T1 HRP20211983TT HRP20211983T HRP20211983T1 HR P20211983 T1 HRP20211983 T1 HR P20211983T1 HR P20211983T T HRP20211983T T HR P20211983TT HR P20211983 T HRP20211983 T HR P20211983T HR P20211983 T1 HRP20211983 T1 HR P20211983T1
- Authority
- HR
- Croatia
- Prior art keywords
- defensin
- use according
- combination
- medication
- concentration
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 2
- 210000000130 stem cell Anatomy 0.000 title claims 2
- 230000004936 stimulating effect Effects 0.000 title 1
- 102000000541 Defensins Human genes 0.000 claims 23
- 108010002069 Defensins Proteins 0.000 claims 23
- 230000037303 wrinkles Effects 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 101710193393 Alpha-defensin 5 Proteins 0.000 claims 1
- 102100026887 Beta-defensin 103 Human genes 0.000 claims 1
- 101710125296 Beta-defensin 3 Proteins 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 241000282693 Cercopithecidae Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 101000981765 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 6 Proteins 0.000 claims 1
- 102100024140 Leucine-rich repeat-containing G-protein coupled receptor 6 Human genes 0.000 claims 1
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
- 241000212749 Zesius chrysomallus Species 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 210000001723 extracellular space Anatomy 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000001788 irregular Effects 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 230000001483 mobilizing effect Effects 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 229940126702 topical medication Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
Claims (8)
1. Upotreba kombinacije prvog defenzina i drugog defenzina u mobilizaciji matičnih stanica LGR6+ u međustanični prostor radi smanjivanja jednog ili više od dubine bora, duljine bora, širine bora, veličine pora, nepravilnosti teksture površine kože, masnosti, smeđih mrlja, te crvenih mrlja kod neozljeđene kože, naznačena time što je kombinacija prvog i drugog defenzina kombinacija α-defenzina 5 i β-defenzina 3.
2. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što se prvi defenzin bira iz skupina koju čine sintetski defenzin, rekombinantni defenzin, ljudski defenzin, majmunski defenzin, mišji defenzin, štakorski defenzin, goveđi defenzin, ovčji defenzin, konjski defenzin, kunićji defenzin, svinjski defenzin, pseći defenzin, te mačji defenzin.
3. Upotreba u skladu s bilo kojim od patentnih zahtjeva 1 ili 2, naznačena time što prvi defenzin dolazi u subantimikrobno djelotvornoj koncentraciji, manjoj od 1 mg/ml.
4. Upotreba u skladu s bilo kojim od patentnih zahtjeva 1 do 3, naznačena time što prvi defenzin dolazi u subantimikrobno djelotvornoj koncentraciji od 0,01 ng/ml do 100 ng/ml.
5. Upotreba u skladu s bilo kojim od patentnih zahtjeva 1 ili 2, naznačena time što se prvi defenzin primjenjuje topikalno kod 0,1 do 500 mg/cm2.
6. Upotreba u skladu s bilo kojim od patentnih zahtjeva 1 do 3 i 5, naznačena time što se prilikom upotrebe primjenjuje topikalni medikament.
7. Upotreba u skladu s patentnim zahtjevom 6, naznačena time što je medikament šampon, vodica za pranje lica, losion za tijelo, ili krema koja sadrži prvi defenzin u koncentraciji od 1 ng/ml do 10 mg/ml.
8. Upotreba u skladu s patentnim zahtjevom 6 ili 7, naznačena time što je medikament liposomska formulacija koja sadrži prvi i drugi defenzin, gdje je koncentracija defenzina do 10 mg/ml.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462014044P | 2014-06-18 | 2014-06-18 | |
| EP19190130.5A EP3586821B1 (en) | 2014-06-18 | 2015-06-16 | Stem cell stimulating compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20211983T1 true HRP20211983T1 (hr) | 2022-08-19 |
Family
ID=54936047
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20211983TT HRP20211983T1 (hr) | 2014-06-18 | 2015-06-16 | Pripravci za i postupci stimuliranja matičnih stanica |
| HRP20191935TT HRP20191935T1 (hr) | 2014-06-18 | 2019-10-23 | Pripravci za stimuliranje matičnih stanica |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20191935TT HRP20191935T1 (hr) | 2014-06-18 | 2019-10-23 | Pripravci za stimuliranje matičnih stanica |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US11491096B2 (hr) |
| EP (2) | EP3586821B1 (hr) |
| CY (2) | CY1122333T1 (hr) |
| DK (2) | DK3586821T3 (hr) |
| ES (2) | ES2903108T3 (hr) |
| HR (2) | HRP20211983T1 (hr) |
| HU (1) | HUE057737T2 (hr) |
| LT (2) | LT3157504T (hr) |
| PL (2) | PL3586821T3 (hr) |
| PT (2) | PT3586821T (hr) |
| RS (1) | RS62981B1 (hr) |
| SI (1) | SI3586821T1 (hr) |
| WO (1) | WO2015195677A1 (hr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3586821B1 (en) * | 2014-06-18 | 2021-12-01 | Medicell Technologies, LLC | Stem cell stimulating compositions and methods |
| SI3389620T1 (sl) | 2015-12-15 | 2023-01-31 | Medicell Technologies, Llc | Sestavki, ki stimulirajo izvorne celice in postopki zdravljenja melazme |
| WO2018013142A1 (en) * | 2016-07-15 | 2018-01-18 | Medicell Technologies Llc | Compositions and methods for providing hair growth |
| CN109692130B (zh) * | 2019-01-30 | 2022-06-21 | 威海同丰海洋生物科技有限公司 | 一种含有防御素的面膜液及其制备方法 |
| CN109718127B (zh) * | 2019-01-30 | 2022-08-09 | 荣成市吉海生物科技有限公司 | 一种非离子型杀菌消炎洗面奶及其制备方法 |
| CN109692129B (zh) * | 2019-01-30 | 2022-06-21 | 威海同丰海洋生物科技有限公司 | 一种含有防御素的剃须膏及其制备方法 |
| JP6735887B2 (ja) * | 2019-08-22 | 2020-08-05 | 富士フイルム株式会社 | 間葉系幹細胞の細胞老化抑制剤、間葉系幹細胞の細胞老化抑制用皮膚外用組成物、間葉系幹細胞の細胞老化抑制用機能性飲食品、及び間葉系幹細胞の細胞老化抑制方法 |
| IT202100018542A1 (it) * | 2021-07-14 | 2023-01-14 | Clever Bioscience S R L | Liposomi contenenti combinazioni antimicrobiche sinergiche a base di peptidi selezionati e acidi grassi |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3689668A (en) * | 1967-10-18 | 1972-09-05 | Emile Leon Piette | Method of alleviating wrinkles on skin |
| US5242902A (en) * | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
| FR2767832B1 (fr) * | 1997-08-29 | 2001-08-10 | Genset Sa | Polypeptide defensine humaine def-x, adn genomique et adnc, composition les contenant et applications au diagnostic et au traitement therapeutique |
| US6984622B2 (en) * | 1998-03-25 | 2006-01-10 | The Regents Of The University Of California | Use of lipopolysaccharides to manage corneal infections and wounds |
| EP1519750A2 (en) * | 2002-03-28 | 2005-04-06 | Exponential Biotherapies, Inc. | Oxygenating agents for enhancing host responses to microbial infections |
| US8119791B2 (en) * | 2003-12-17 | 2012-02-21 | Avon Products, Inc. | si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation |
| DE102005014687A1 (de) * | 2005-03-29 | 2006-10-12 | Henkel Kgaa | Zusammensetzung enthaltend ß-Defensin 2 |
| US8202835B2 (en) * | 2005-06-17 | 2012-06-19 | Yitzchak Hillman | Disease treatment via antimicrobial peptides or their inhibitors |
| US7528107B2 (en) * | 2005-11-30 | 2009-05-05 | Auburn University | Methods of treating inflammation in mammalian tissues comprising administering human alpha-defensins |
| WO2008133928A2 (en) * | 2007-04-27 | 2008-11-06 | The Gi Company, Inc. | Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders |
| DE102009044970A1 (de) * | 2009-07-23 | 2011-01-27 | Henkel Ag & Co. Kgaa | Verwendung von humanem beta-Defensin zur Beeinflussung des natürlichen Pigmentierungsprozesses |
| ES2384060B1 (es) * | 2010-03-24 | 2013-09-23 | Lipotec S.A. | Cápsulas de nanopartículas lipídicas. |
| US9034302B2 (en) * | 2011-04-11 | 2015-05-19 | L'oreal | Mineral sunscreen composition and process for protecting skin from photodamage and aging |
| WO2012155048A1 (en) * | 2011-05-11 | 2012-11-15 | Wisconsin Alumni Research Foundation | Liposome-encapsulated hydrogels for use in a drug delivery system |
| BR112013030874B8 (pt) * | 2011-06-02 | 2021-09-14 | Univ California | Uso de uma theta-defensina ou análogo da mesma para tratar uma condição inflamatória crônica |
| US20130310326A1 (en) * | 2012-05-18 | 2013-11-21 | Rapid Pathogen Screening, Inc. | Histatin for Corneal Wound Healing and Ocular Surface Disease |
| WO2014004339A2 (en) | 2012-06-25 | 2014-01-03 | Elc Management Llc | Method for stimulating cellular beta defensins |
| EP3586821B1 (en) * | 2014-06-18 | 2021-12-01 | Medicell Technologies, LLC | Stem cell stimulating compositions and methods |
| SI3389620T1 (sl) * | 2015-12-15 | 2023-01-31 | Medicell Technologies, Llc | Sestavki, ki stimulirajo izvorne celice in postopki zdravljenja melazme |
| WO2018013142A1 (en) * | 2016-07-15 | 2018-01-18 | Medicell Technologies Llc | Compositions and methods for providing hair growth |
-
2015
- 2015-06-16 EP EP19190130.5A patent/EP3586821B1/en active Active
- 2015-06-16 RS RS20220191A patent/RS62981B1/sr unknown
- 2015-06-16 PL PL19190130T patent/PL3586821T3/pl unknown
- 2015-06-16 HU HUE19190130A patent/HUE057737T2/hu unknown
- 2015-06-16 PT PT191901305T patent/PT3586821T/pt unknown
- 2015-06-16 SI SI201531800T patent/SI3586821T1/sl unknown
- 2015-06-16 WO PCT/US2015/036049 patent/WO2015195677A1/en active Application Filing
- 2015-06-16 HR HRP20211983TT patent/HRP20211983T1/hr unknown
- 2015-06-16 DK DK19190130.5T patent/DK3586821T3/da active
- 2015-06-16 ES ES19190130T patent/ES2903108T3/es active Active
- 2015-06-16 PL PL15810115T patent/PL3157504T3/pl unknown
- 2015-06-16 LT LT15810115T patent/LT3157504T/lt unknown
- 2015-06-16 EP EP15810115.4A patent/EP3157504B1/en active Active
- 2015-06-16 DK DK15810115T patent/DK3157504T3/da active
- 2015-06-16 ES ES15810115T patent/ES2754523T3/es active Active
- 2015-06-16 LT LTEP19190130.5T patent/LT3586821T/lt unknown
- 2015-06-16 PT PT158101154T patent/PT3157504T/pt unknown
-
2016
- 2016-12-19 US US15/383,423 patent/US11491096B2/en active Active
-
2019
- 2019-10-23 HR HRP20191935TT patent/HRP20191935T1/hr unknown
- 2019-11-01 CY CY20191101142T patent/CY1122333T1/el unknown
-
2022
- 2022-01-18 CY CY20221100042T patent/CY1125101T1/el unknown
- 2022-07-29 US US17/815,972 patent/US20220401337A1/en active Pending
- 2022-09-09 US US17/930,842 patent/US20230000750A1/en active Pending
- 2022-09-09 US US17/930,840 patent/US20230000749A1/en active Pending
- 2022-09-09 US US17/930,845 patent/US20230000751A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK3586821T3 (da) | 2022-01-17 |
| EP3157504A4 (en) | 2018-01-03 |
| EP3586821A1 (en) | 2020-01-01 |
| US20230000750A1 (en) | 2023-01-05 |
| US20220401337A1 (en) | 2022-12-22 |
| WO2015195677A4 (en) | 2016-01-21 |
| CY1125101T1 (el) | 2023-06-09 |
| EP3157504A1 (en) | 2017-04-26 |
| PL3586821T3 (pl) | 2022-03-14 |
| WO2015195677A1 (en) | 2015-12-23 |
| RS62981B1 (sr) | 2022-03-31 |
| DK3157504T3 (da) | 2019-11-04 |
| EP3157504B1 (en) | 2019-08-07 |
| US20230000749A1 (en) | 2023-01-05 |
| SI3586821T1 (sl) | 2022-04-29 |
| US11491096B2 (en) | 2022-11-08 |
| PT3586821T (pt) | 2022-04-11 |
| CY1122333T1 (el) | 2021-01-27 |
| EP3586821B1 (en) | 2021-12-01 |
| HUE057737T2 (hu) | 2022-06-28 |
| US20230000751A1 (en) | 2023-01-05 |
| ES2754523T3 (es) | 2020-04-20 |
| HRP20191935T1 (hr) | 2020-05-15 |
| LT3586821T (lt) | 2022-03-25 |
| ES2903108T3 (es) | 2022-03-31 |
| PT3157504T (pt) | 2019-11-11 |
| PL3157504T3 (pl) | 2020-03-31 |
| US20170157015A1 (en) | 2017-06-08 |
| LT3157504T (lt) | 2019-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20211983T1 (hr) | Pripravci za i postupci stimuliranja matičnih stanica | |
| PH12016502254A1 (en) | Keratin treatment formulations and methods | |
| CL2014002564A1 (es) | Composiciones para tratamiento de agua que comprende un coagulante que contiene aluminio y un polisacarido no derivado natural, en donde la relacion entre el polisacarido y el coagulante es entre 1:10 hasta 1:100; y métodos de uso. | |
| BR112015020371A2 (pt) | composição cosmética, processo para preparar uma composição cosmética, kit cosmético e dispositivos para maquiagem e/ou cuidados com materiais de queratina, em particular a pele e/ou os lábios. | |
| UY36542A (es) | Formulaciones farmacéuticas para anticuerpos anti-tnf-alfa | |
| NZ716033A (en) | Treatment of papulopustular rosacea with ivermectin | |
| PH12019502062A1 (en) | Skin barrier composition | |
| AR097146A1 (es) | Composición para alimentación de rumiantes y método para prepararla | |
| MX2018005796A (es) | Reduccion de la sensacion de picazon en la piel. | |
| WO2014043230A3 (en) | Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof | |
| BR112014030553A2 (pt) | uso cosmético, como agente para prevenir e/ou tratar um defeito estético na pele e/ou seus apêndices, método relacionado, composto, e composição dermatológica | |
| MX2021013354A (es) | Metodos para tratar y/o prevenir queratosis actinica. | |
| ES2895910T3 (es) | Composiciones multifásicas | |
| PH12018500910A1 (en) | Novel method of use and compositions | |
| BR112014031706A2 (pt) | composição farmacêutica oral; forma de composição farmacêutica oral; método de redução de efeito de alimento de itraconazol em um indivíduo; método de redução de variabilidade em um mesmo indivíduo de itraconazol; método de redução de variabilidade entre indivíduos de itraconazol; método de tratamento de onicomicose; método de tratamento de uma doença ou afecção e método de tratamento de câncer | |
| BR112015025726A2 (pt) | composição multi-funcional para formulações cosméticas | |
| MX2016000136A (es) | Mezclas conservantes sinergicas. | |
| WO2014140485A3 (fr) | Composition cosmétique ou dermatologique et son utilisation | |
| ZA201504783B (en) | Cosmetic or dermatological composition comprising a merocyanine and a uva-screening agent of the amino-substituted 2-hydroxybenzophenone type and/or a hydrophilic organic uva-screening agent | |
| WO2015063613A3 (en) | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents | |
| HRP20201630T1 (hr) | Sastavi i postupci za liječenje kožnog t-staničnog limfoma | |
| AR104721A1 (es) | Fragmento fab anti-ngf humano | |
| WO2015112866A3 (en) | Compounds and methods for increasing hair growth | |
| WO2015023694A3 (en) | Method for enhancing tumor growth | |
| DE602007005464D1 (de) | Zusammensetzung zur kosmetischen oder pharmazeutisch-dermatologischen verwendung |